| HOME | HELP | E-MAIL ALERTS | SEARCH |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL PRACTICE GUIDELINE |
The clinical practice guideline on otitis media with effusion (OME) provides evidence-based recommendations on diagnosing and managing OME in children. This is an update of the 1994 clinical practice guideline "Otitis Media With Effusion in Young Children," which was developed by the Agency for Healthcare Policy and Research (now the Agency for Healthcare Research and Quality). In contrast to the earlier guideline, which was limited to children 1 to 3 years old with no craniofacial or neurologic abnormalities or sensory deficits, the updated guideline applies to children aged 2 months through 12 years with or without developmental disabilities or underlying conditions that predispose to OME and its sequelae. The American Academy of Pediatrics, American Academy of Family Physicians, and American Academy of Otolaryngology-Head and Neck Surgery selected a subcommittee composed of experts in the fields of primary care, otolaryngology, infectious diseases, epidemiology, hearing, speech and language, and advanced-practice nursing to revise the OME guideline.
The subcommittee made a strong recommendation that clinicians use pneumatic otoscopy as the primary diagnostic method and distinguish OME from acute otitis media.
The subcommittee made recommendations that clinicians should 1) document the laterality, duration of effusion, and presence and severity of associated symptoms at each assessment of the child with OME, 2) distinguish the child with OME who is at risk for speech, language, or learning problems from other children with OME and more promptly evaluate hearing, speech, language, and need for intervention in children at risk, and 3) manage the child with OME who is not at risk with watchful waiting for 3 months from the date of effusion onset (if known) or diagnosis (if onset is unknown).
The subcommittee also made recommendations that 4) hearing testing be conducted when OME persists for 3 months or longer or at any time that language delay, learning problems, or a significant hearing loss is suspected in a child with OME, 5) children with persistent OME who are not at risk should be reexamined at 3- to 6-month intervals until the effusion is no longer present, significant hearing loss is identified, or structural abnormalities of the eardrum or middle ear are suspected, and 6) when a child becomes a surgical candidate (tympanostomy tube insertion is the preferred initial procedure). Adenoidectomy should not be performed unless a distinct indication exists (nasal obstruction, chronic adenoiditis); repeat surgery consists of adenoidectomy plus myringotomy with or without tube insertion. Tonsillectomy alone or myringotomy alone should not be used to treat OME.
The subcommittee made negative recommendations that 1) population-based screening programs for OME not be performed in healthy, asymptomatic children, and 2) because antihistamines and decongestants are ineffective for OME, they should not be used for treatment; antimicrobials and corticosteroids do not have long-term efficacy and should not be used for routine management.
The subcommittee gave as options that 1) tympanometry can be used to confirm the diagnosis of OME and 2) when children with OME are referred by the primary clinician for evaluation by an otolaryngologist, audiologist, or speech-language pathologist, the referring clinician should document the effusion duration and specific reason for referral (evaluation, surgery) and provide additional relevant information such as history of acute otitis media and developmental status of the child. The subcommittee made no recommendations for 1) complementary and alternative medicine as a treatment for OME, based on a lack of scientific evidence documenting efficacy, or 2) allergy management as a treatment for OME, based on insufficient evidence of therapeutic efficacy or a causal relationship between allergy and OME. Last, the panel compiled a list of research needs based on limitations of the evidence reviewed.
The purpose of this guideline is to inform clinicians of evidence-based methods to identify, monitor, and manage OME in children aged 2 months through 12 years. The guideline may not apply to children more than 12 years old, because OME is uncommon and the natural history is likely to differ from younger children who experience rapid developmental change. The target population includes children with or without developmental disabilities or underlying conditions that predispose to OME and its sequelae. The guideline is intended for use by providers of health care to children, including primary care and specialist physicians, nurses and nurse practitioners, physician assistants, audiologists, speech-language pathologists, and child-development specialists. The guideline is applicable to any setting in which children with OME would be identified, monitored, or managed.
This guideline is not intended as a sole source of guidance in evaluating children with OME. Rather, it is designed to assist primary care and other clinicians by providing an evidence-based framework for decision-making strategies. It is not intended to replace clinical judgment or establish a protocol for all children with this condition and may not provide the only appropriate approach to diagnosing and managing this problem.
Key Words: acute otitis media • antibacterial • antibiotic
Abbreviations: OME, otitis media with effusion • AOM, acute otitis media • AAP, American Academy of Pediatrics • AHRQ, Agency for Healthcare Research and Quality • EPC, Southern California Evidence-Based Practice Center • CAM, complementary and alternative medicine • HL, hearing level
The following policy statement is retired:
This article has been cited by other articles:
 |
|
 |
|
  S. B. Meropol, H. A. Glick, and D. A. Asch Age Inconsistency in the American Academy of Pediatrics Guidelines for Acute Otitis Media Pediatrics, April 1, 2008; 121(4): 657 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Koopman, A. W. Hoes, P. P. Glasziou, C. L. Appelman, P. Burke, D. P. McCormick, R. A. Damoiseaux, N. Le Saux, and M. M. Rovers Antibiotic Therapy to Prevent the Development of Asymptomatic Middle Ear Effusion in Children With Acute Otitis Media: A Meta-analysis of Individual Patient Data Arch Otolaryngol Head Neck Surg, February 1, 2008; 134(2): 128 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Berman Otitis Media, Shared Decision Making, and Enhancing Value in Pediatric Practice Arch Pediatr Adolesc Med, February 1, 2008; 162(2): 186 - 188. [Full Text] [PDF]
|
|
|
|
|
|
S. Keyhani, L. C. Kleinman, M. Rothschild, J. M. Bernstein, R. Anderson, M. Simon, and M. Chassin Clinical Characteristics of New York City Children Who Received Tympanostomy Tubes in 2002 Pediatrics, January 1, 2008; 121(1): e24 - e33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Joint Committee on Infant Hearing Year 2007 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs Pediatrics, October 1, 2007; 120(4): 898 - 921. [Full Text] [PDF]
|
|
|
|
|
|
J. Chianese, A. Hoberman, J. L. Paradise, D. K. Colborn, D. Kearney, H. E. Rockette, and M. Kurs-Lasky Spectral Gradient Acoustic Reflectometry Compared With Tympanometry in Diagnosing Middle Ear Effusion in Children Aged 6 to 24 Months Arch Pediatr Adolesc Med, September 1, 2007; 161(9): 884 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. C. Serpanos and F. Jarmel Quantitative and Qualitative Follow-Up Outcomes From a Preschool Audiologic Screening Program: Perspectives Over a Decade Am J Audiol, June 1, 2007; 16(1): 4 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lindbaek Prompt insertion of tympanostomy tubes in infants and toddlers with persistent middle ear effusion did not improve developmental outcomes at 9-11 years of age Evid. Based Med., June 1, 2007; 12(3): 80 - 80. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Paradise, H. M. Feldman, T. F. Campbell, C. A. Dollaghan, H. E. Rockette, D. L. Pitcairn, C. G. Smith, D. K. Colborn, B. S. Bernard, M. Kurs-Lasky, et al. Tympanostomy Tubes and Developmental Outcomes at 9 to 11 Years of Age N. Engl. J. Med., January 18, 2007; 356(3): 248 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Berman The End of an Era in Otitis Research N. Engl. J. Med., January 18, 2007; 356(3): 300 - 302. [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Orr, K. L. Matson, and B. J. Cowles Nonprescription Medication Use by Infants and Children: Product Labeling Versus Evidence-Based Medicine Journal of Pharmacy Practice, October 1, 2006; 19(5): 286 - 294. [Abstract] [PDF]
|
|
|
|
|
|
D. A. Varrasso Otitis Media: The Need for a New Paradigm in Medical Education Pediatrics, October 1, 2006; 118(4): 1731 - 1733. [Full Text] [PDF]
|
|
|
|
|
|
C. G. Smith, J. L. Paradise, D. L. Sabo, H. E. Rockette, M. Kurs-Lasky, B. S. Bernard, and D. K. Colborn Tympanometric Findings and the Probability of Middle-Ear Effusion in 3686 Infants and Young Children Pediatrics, July 1, 2006; 118(1): 1 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I.O. Plasschaert, M. M. Rovers, A. G. M. Schilder, T. J. M. Verheij, and E. Hak Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995-2003. Pediatrics, June 1, 2006; 117(6): 1879 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Ahn, T. H. Yoon, K. H. Pae, T. S. Kim, J. W. Chung, and K.-S. Lee Clinical Manifestations and Risk Factors of Children Receiving Triple Ventilating Tube Insertions for Treatment of Recurrent Otitis Media With Effusion Pediatrics, June 1, 2006; 117(6): e1119 - e1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Principles of Appropriate Use for Upper Respiratory Tract Infections Red Book, January 1, 2006; 2006(1): 737a - 740a. [Full Text]
|
|
|
|
|
|
S. Berman Long-term Sequelae of Ventilating Tubes: Implications for Management of Otitis Media With Effusion Arch Pediatr Adolesc Med, December 1, 2005; 159(12): 1183 - 1185. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Paradise, T. F. Campbell, C. A. Dollaghan, H. M. Feldman, B. S. Bernard, D. K. Colborn, H. E. Rockette, J. E. Janosky, D. L. Pitcairn, M. Kurs-Lasky, et al. Developmental Outcomes after Early or Delayed Insertion of Tympanostomy Tubes N. Engl. J. Med., August 11, 2005; 353(6): 576 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nafstad, B. Brunekreef, A. Skrondal, and W. Nystad Early Respiratory Infections, Asthma, and Allergy: 10-Year Follow-up of the Oslo Birth Cohort Pediatrics, August 1, 2005; 116(2): e255 - e262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hoover and O. F. Roddey The Overlooked Importance of Tympanic Membrane Bulging Pediatrics, February 1, 2005; 115(2): 513 - 513. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Paradise and C. D. Bluestone Consultation With the Specialist: Tympanostomy Tubes: A Contemporary Guide to Judicious Use Pediatr. Rev., February 1, 2005; 26(2): 61 - 66. [Full Text] [PDF]
|
|
|
|
 |
|
 23 Apr 2004 to 23 Jul 2004 Evid. Based Nurs., October 1, 2004; 7(4): e4 - e4. [Full Text] [PDF]
|
|
|
|
|
|
Other articles noted Evid. Based Med., September 1, 2004; 9(5): e5 - e5. [Full Text] [PDF]
|
|
|
|
 |
|
 Guideline Update for Otitis Media with Effusion in Children Journal Watch Pediatrics and Adolescent Medicine, July 12, 2004; 2004(712): 1 - 1. [Full Text]
|
|
|
|
 |
|
 Management of Acute Otitis Media and Otitis Media with Effusion Journal Watch Infectious Diseases, June 4, 2004; 2004(604): 2 - 2. [Full Text]
|
|
| HOME | HELP | E-MAIL ALERTS | SEARCH |
